Return on Tangible Equity (Annual)

Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity

Krystal Biotech, Inc. (KRYS) had Return on Tangible Equity of 16.80% for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$389.13M
Net Income	$204.83M
Cost of Goods Sold	$23.05M
Gross Profit	$366.08M
Operating Expenses	$227.84M
Operating Income	$161.29M
Non-Operating Income/Expense	$28.18M
Pre-Tax Income	$189.47M
Normalized Pre-Tax Income	$189.47M
Income after Taxes	$204.83M
Income from Continuous Operations	$204.83M
Consolidated Net Income/Loss	$204.83M
Normalized Income after Taxes	$204.83M
EBIT	$161.29M
EBITDA	$167.85M
Weighted-Average Shares Outstanding (Basic)	28.94M
Weighted-Average Shares Outstanding (Diluted)	29.95M
Earnings per Share (EPS) (Basic)	$7.08
Earnings per Share (EPS) (Diluted)	$6.84
Balance Sheet Financials
Current Assets	$1.02B
Property, Plant, and Equipment	$150.78M
Long-Term Assets	$309.19M
Total Assets	$1.33B
Current Liabilities	$102.94M
Long-Term Debt	--
Long-Term Liabilities	$11.29M
Total Liabilities	$114.23M
Common Equity	$1.22B
Tangible Shareholders Equity	$1.22B
Shareholders Equity	$1.22B
Common Shares Outstanding	29.19M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$200.87M
Cash Flow from Investing Activities	$-58.42M
Cash Flow from Financial Activities	$8.71M
Beginning Cash	$344.87M
End Cash	$496.30M
Increase/Decrease in Cash	$151.44M
Stock-Based Compensation	$54.51M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	9.95
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	--
Debt to Equity Ratio	--
Gross Margin	94.08%
Operating Margin	41.45%
EBIT Margin	41.45%
EBITDA Margin	43.13%
Pre-Tax Profit Margin	48.69%
Profit Margin	52.64%
Free Cash Flow	$189.35M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.29
Inventory Turnover	0.57
Receiveable Turnover	3.05
Days Sales in Receivables	119.52
Return on Equity	16.80%
Return on Tangible Equity	16.80%
Return on Assets	15.36%
Return on Investments	16.80%
Book Value Per Share	$41.78
Free Cash Flow per Share	$6.32
Operating Cash Flow per Share	$6.71

Data from Zacks Investment Research, Inc.